Tovero Bio is harnessing the promise of vectorized RNAi technology to redefine expectations for the use of advanced precision medicine in genetic disease. Our therapeutic candidates leverage existing cellular machinery, mirroring innate processes to directly address genetic drivers of disease. Our goal is to transform outcomes for people with challenging neurological diseases who have no therapeutic options today.